Galvus Met Tablet (Vildagliptin + Metformin)

When Using Galvus Met Tablet (Vildagliptin + Metformin), It Is Important To Take Certain Precautions

• Renal Impairment: Caution is advised in patients with renal impairment, as metformin can accumulate in the bloodstream, increasing the risk of lactic acidosis. Dosage adjustments or discontinuation might be necessary.
• Hypersensitivity: Individuals with known hypersensitivity to Vildagliptin, Metformin, or any other component of the tablet should avoid its use.
• Surgery and Imaging Procedures: Temporary discontinuation of Vildagliptin + Metformin Tablet may be recommended before undergoing surgeries or certain imaging procedures with contrast agents to reduce the risk of lactic acidosis.
• Pregnancy and Breastfeeding: The safety of this medication during pregnancy and breastfeeding hasn't been established. Consultation with a healthcare provider is essential for weighing the potential benefits against the risks.
• Hypoglycemia Risk: When used in combination with other antidiabetic medications, there's a heightened potential for hypoglycemia. Regular monitoring of blood sugar levels is crucial.

Some of the specific indications for Galvus Met Tablet (Vildagliptin + Metformin) include 

Type 2 Diabetes Mellitus: Vildagliptin + Metformin Tablet, in its Galvus Met form, is primarily indicated for the management of type 2 diabetes mellitus. It helps lower blood sugar levels by improving insulin sensitivity, reducing hepatic glucose production, and enhancing glucose-dependent insulin secretion.

A number of the follow-on effects of Galvus Met Tablet (Vildagliptin + Metformin)

• Gastrointestinal Distress: Common side effects may encompass nausea, vomiting, diarrhea, and abdominal discomfort. These symptoms usually diminish as the body adapts to the medication.
• Hypoglycemia: When Vildagliptin + Metformin Tablet is administered alongside other antidiabetic agents, there's a potential risk of inducing hypoglycemia, which can manifest as dizziness, shakiness, sweating, and confusion.
• Lactic Acidosis: Although rare, metformin can lead to a severe condition called lactic acidosis, characterized by muscle pain, rapid breathing, cold or numb extremities, and unusual weakness. This requires immediate medical intervention.
• Skin Reactions: Some individuals might experience skin reactions like rash or itching, which should be reported to a healthcare professional if they persist or worsen.
• Liver Function: Monitoring liver function is essential, as rare cases of liver enzyme elevation have been observed with the use of Vildagliptin + Metformin Tablet.

Frequently Asked Queries About Galvus Met Tablet (Vildagliptin + Metformin)

Q1. Can Galvus Met be taken with other diabetes medications?

Yes, Galvus Met can be used alongside other diabetes medications, but close monitoring is essential to prevent hypoglycemia. Consult your healthcare provider before making any changes to your medication regimen.

Q2. Is Galvus Met suitable for elderly individuals?

Yes, Galvus Met can be prescribed to elderly individuals with type 2 diabetes. However, due to potential kidney function decline with age, dosage adjustments and renal function monitoring might be necessary.

Q3. Can Galvus Met cause weight changes?

Galvus Met is less likely to cause weight gain and may even contribute to modest weight loss due to its mechanisms of action. However, individual responses may vary, and lifestyle factors also play a role.

Q4. How does Galvus Met differ from insulin therapy?

Galvus Met enhances insulin sensitivity and glucose-dependent insulin secretion, whereas insulin therapy directly replaces or supplements insulin. Galvus Met is often used earlier in the course of type 2 diabetes before insulin becomes necessary.

Q5. Is Galvus Met safe for people with liver issues?

Galvus Met requires cautious use in individuals with liver issues, as rare cases of liver enzyme elevation have been reported. Regular liver function tests are recommended to monitor for any adverse effects on liver health.

Significant Drug Interactions that Require Attention For Galvus Met Tablet (Vildagliptin + Metformin)

• Insulin and Sulfonylureas: Combining Vildagliptin + Metformin Tablet with insulin or sulfonylureas increases the risk of hypoglycemia. Dose adjustments of these agents might be necessary.
• Diuretics: Certain diuretics can lead to dehydration, potentially increasing the risk of lactic acidosis when used concurrently with metformin.
• Cimetidine: Cimetidine, a medication used for gastric issues, may interfere with the elimination of metformin, leading to elevated levels in the bloodstream.
• Iodinated Contrast Agents: There's a risk of lactic acidosis when using metformin alongside iodinated contrast agents for imaging procedures. Temporary discontinuation might be advised.
• Beta-2 Agonists: Beta-2 agonists like albuterol may elevate blood sugar levels, necessitating closer monitoring when used alongside Vildagliptin + Metformin Tablet.